Get access

Amiodarone versus other pharmacological interventions for prevention of sudden cardiac death

  • Protocol
  • Intervention

Authors

  • Juan Carlos Claro,

    Corresponding author
    1. Faculty of Medicine, Pontificia Universidad Católica de Chile, Department of Internal Medicine, Evidence Based Health Care Program, Santiago, Region Metropolitana, Chile
    • Juan Carlos Claro, Department of Internal Medicine, Evidence Based Health Care Program, Faculty of Medicine, Pontificia Universidad Católica de Chile, Lira 63, Santiago, Region Metropolitana, Chile. xuanca@gmail.com.

    Search for more papers by this author
  • Roberto Candia,

    1. Faculty of Medicine, Pontificia Universidad Católica de Chile, Department of Internal Medicine, Evidence Based Health Care Program, Santiago, Region Metropolitana, Chile
    Search for more papers by this author
  • Gabriel Rada,

    1. Faculty of Medicine, Pontificia Universidad Católica de Chile, Department of Internal Medicine, Evidence Based Health Care Program, Santiago, Region Metropolitana, Chile
    Search for more papers by this author
  • Francisco Larrondo,

    1. Edificio Clinico, 5th floor, Clinica Alemana, Department of Intensive Care Medicine, Vitacura, Region Metropolitana, Chile
    Search for more papers by this author
  • Fernando Baraona,

    1. Faculty of Medicine, Pontificia Universidad Católica de Chile, Department of Cardiovascular Diseases, Santiago, Region Metropolitana, Chile
    Search for more papers by this author
  • Luz M Letelier

    1. Faculty of Medicine, Pontificia Universidad Católica de Chile, Department of Internal Medicine, Evidence Based Health Care Program, Santiago, Region Metropolitana, Chile
    Search for more papers by this author

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To evaluate the effectiveness of amiodarone as primary or secondary prevention in sudden cardiac death (SCD) compared with placebo or any other antiarrythmics in patients with high risk for sudden cardiac death, or who have recovered from a cardiac arrest or a syncope due to VT/VF. We aim to conduct a subgroup analysis for patients with or without ICD.

Get access to the full text of this article